SB
TEVA icon

SIG Brokerage’s Teva Pharmaceuticals TEVA Stock Holding History

SIG Brokerage’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,500
Closed -$234K – 969
2025
Q4 		$234K Buy
+7,500
New +$185K 0.01% 574

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

SIG Brokerage's TEVA Position: Q2 2026 in Review

SIG Brokerage increased its Teva Pharmaceuticals (TEVA) stake by 32% in Q2 2026, buying an estimated $412K and bringing the position to 50,850 shares worth $1.72M. The position accounts for 0.03% of the portfolio, ranked #361.

SIG Brokerage first reported a position in TEVA in Q4 2024 and has held it in 4 quarters since. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • SIG Brokerage held 50,850 shares of Teva Pharmaceuticals worth $1.72M as of Q2 2026.
  • SIG Brokerage bought 12,383 Teva Pharmaceuticals shares in Q2 2026, an estimated $412K.
  • Teva Pharmaceuticals made up 0.03% of SIG Brokerage's portfolio in Q2 2026, its #361 holding.
  • SIG Brokerage first reported a position in Teva Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • 675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on SIG Brokerage's 13F filing for Q2 2026, filed 14 Aug 2026.